Overexpression of HGF Promotes HBV-Induced Hepatocellular Carcinoma Progression and Is an Effective Indicator for Met-Targeting Therapy.

Xie, Qian; Su, Yanli; Dykema, Karl; Johnson, Jennifer; Koeman, Julie; De Giorgi, Valeria; Huang, Alan; Schlegel, Robert; Essenburg, Curt; Kang, Liang; Iwaya, Keiichi; Seki, Shuhji; Khoo, Sok Kean; Zhang, Boheng; Buonaguro, Franco; Marincola, Francesco M; Furge, Kyle; Vande Woude, George F; Shinomiya, Nariyoshi

Xie, Qian; Su, Yanli; Dykema, Karl; Johnson, Jennifer; Koeman, Julie; De Giorgi, Valeria; Huang, Alan; Schlegel, Robert; Essenburg, Curt; Kang, Liang; Iwaya, Keiichi; Seki, Shuhji; Khoo, Sok Kean; Zhang, Boheng; Buonaguro, Franco; Marincola, Francesco M; Furge, Kyle; Vande Woude, George F; Shinomiya, Nariyoshi.

Afiliação

Xie Q; Laboratory of Molecular Oncology, Van Andel Research Institute, Grand Rapids, MI, USA.

Genes Cancer ; 4(7-8): 247-60, 2013 Jul.

Article em En | MEDLINE | ID: mdl-24167653

Palavras-chave

MET; hepatitis B; hepatocellular carcinoma; hepatocyte growth factor; targeted therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Genes Cancer Ano de publicação: 2013 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google